PHIBRO ANIMAL HEALTH CORP

For the period ended Mar 31, 2025. Filed May 7, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 7, 2025

PAHC$34.61+5.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations


· · Three Months · · Nine Months
For the Periods Ended March 31 · 2025 · 2024 · 2025 · 2024 ·
· · (unaudited) ·
· · (in thousands, except per share amounts) ·
Net sales	$347,825	$263,223	$917,518	$744,515
Cost of goods sold	243,257	183,623	627,585	518,573
Gross profit	104,568	79,600	289,933	225,942
Selling, general and administrative expenses	71,053	59,676	213,186	191,043
Operating income	33,515	19,924	76,747	34,899
Interest expense, net	9,355	4,575	25,992	13,798
Foreign currency (gains) losses, net	(5,528)	2,427	6,609	16,593
Income before income taxes	29,688	12,922	44,146	4,508
Provision for income taxes	8,808	4,517	13,106	2,844
Net income	$20,880	$8,405	$31,040	$1,664

Net income per share
basic	$0.52	$0.21	$0.77	$0.04
diluted	$0.51	$0.21	$0.76	$0.04
Weighted average common shares outstanding
basic	40,520	40,504	40,509	40,504
diluted	40,709	40,520	40,669	40,509

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.